chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2nd dose EL8982.  About 6 hours after 1st vaccine had visual disturbances in left eye, got  a little better after a week or so, but still has a floater in left eye, had 2nd dose and after 72 hours had to leave work (never left work before) to get emergency eye exam - thought I was going blind - diagnosed with "Posterior Vitreous Detachment".  Now I still have a BIG thing in field of vision making it hard to see and "thousands" of tiny black floaters.  Hard to see out of right eye.
No adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 19-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 15-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients).    No concomitant medications were reported. It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. 77 Monovalent doses administered after the BUD to patients 12 and up. It was reported that 37 doses from Lot 059H21A, 26 doses from Lot 065K21A, and 12 doses from Lot 058A22-2A were administered. No treatment information was provided.
tested positive for Covid; tested positive for Covid; This is a spontaneous report from a contactable consumer(patient).  A male patient of an unspecified age first dose received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on 06Jan2021 at single dose for COVID-19 immunization .  The patient medical history and concomitant medications were not reported.  The patient experienced tested positive for COVID on 12Jan2021 with outcome of unknown. Patient was scheduled for second dose on 27Jan2021, while doctors can't agree on whether he should et that second dose or not.    Information about lot/batch number has been requested.
Adverse Events Starting in June 2021, patient experienced continuing severe nerve numbness, tingling pain, and weakness in the Right arm, neck, back, and shoulders.  Patient is so experiencing finger and joints locking, severe inflammation, muscular weakness.  Patient is experiencing floaters in her eyes, frequent nighttime urination, general malaise, fatigue, vomiting, and pain. Insatiable thirst and dry mouth.   Also, Patient is experiencing trouble swallowing while eating. Also, a lingering cough.
This spontaneous report was received from a registered nurse refers to an unspecified number of patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates, patients were vaccinated with PNEUMOVAX 23 injection, (lot #, expiry date, dose, frequency and route of administration not reported). On an unknown dates, patients developed "localized injection site reactions" following the administration of PNEUMOVAX 23. The outcome of the event was unknown. Causality assessment was not provided. No product quality complaint (PQC) was involved. Reporter did not have any further details to provide. No further information provided. Additional information have been requested.
Fever; Body aches; Chills; Headache; This is a spontaneous report from a contactable consumer (patient). A 26-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EP6955), via an unspecified route of administration in left arm on 24Mar2021 at 12:15 PM (at the age of 26 years old) as single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL3248), via an unspecified route of administration in left arm on 03Mar2021 at 02:15 PM (at the age of 26 years old) for covid-19 immunisation. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 25Mar2021 at 08:30 patient experienced fever, body aches, chills and headache. The patient did not received treatment due to the events. The outcome of events was recovered with sequel on an unspecified date in 2021.  Information on Lot/Batch number was available. No further information is expected.
Information has been received from a county health nurse concerning a 6 year old male who on 24-OCT-2001 was vaccinated with varicella virus vaccine live (Oka/Merck). On 10-MAR-2007, the patient developed varicella < 50 lesions. The nurse reported that an outbreak of varicella had taken place in the local school district in April 2007, and this student was identified during the country health investigation. An immunization clinic was conducted in the school where students received a second dose of varicella virus vaccine live (Oka/Merck). This is one of 28 reports received from the same source. No further information is available.
3/12/2021 Presented to the hospital with altered mental status, and was ultimately diagnosed with a urinary tract infection. The patient was admitted for IV antibiotics with resolution of the patient's mental status.
Tingling on face and lips; Tingling on face and lips; Redness; Rash; This is a spontaneous report from a contactable consumer (patient) via medical information team. A female patient of an unspecified age (also reported as aged 61) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported) via an unspecified route of administration, on 29Mar2021 15:00, at dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced a little face tingling with a little redness and rash on the day before the time of report (30Mar2021) and then had some lip tingling on the day of report (31Mar2021). The outcome of the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021; Covid-19 vaccine that were given beyond the 30 day use by date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     It was unknown if patient had any acute illnesses at the time of vaccination and up to one month before. It was unknown if the patient had chronic or long-standing health conditions. It was unknown if any prescriptions, over-the-counter-medications, dietary supplements, or herbal remedies were being taken by the patient at the time of vaccination and/or at the time of the adverse event. It was unknown if other vaccines were given on the same day as Moderna COVID-19 Vaccine to the patient. It was unknown if patient received other vaccines within one month prior to any dose of Moderna COVID-19 Vaccine.  .     On 02-Apr-2022 at 2:15 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022 at 2:15 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   As per the report patient race is given as White.  patient received Second booster dose No concomitant drug information was provided.  Its 30 days Expiry date vaccine went into 2 to 8 °C thaw state on or about to 20-Dec-2021, this vaccine administered until its Mfg date of 04-Apr-2022  No treatment drug information was received.   This case was linked to MOD-2022-542869 (Patient Link).
A few hours after vaccine I felt an intense mania/heightened energy and mood which then crashed into a low mood/depressive state around 4pm. This came with intense headache and fatigue. The next morning on 4/3 I woke up for radiating pain down right side, headache, fatigue, stiff neck, all teeth on left side of mouth felt inflamed and sensitive, swollen lymphs on right side. These symptoms have never gone away completely and it is now 12/10. They all persisted  the past 9 months straight with no relief at all and additionally include bouts of depression, brain fog, comprehension challenges and memory issues. With support of an herbal medicine and other modalities to address information the symptoms subside occasionally for about a week at a time, but return as flare ups regularly. My doctor when I received the vaccine ignored my symptoms repeatedly which caused me to leave the first HCP and find another doctor. I still haven?t received the attention I am needing.  Additionally over months I have been spotting between mentrual cycles and was diagnosed for the first time with a fibroid in my left ovary.
Fever of 99 degrees; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 99 degrees) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced PYREXIA (Fever of 99 degrees). At the time of the report, PYREXIA (Fever of 99 degrees) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Jan-2021, Body temperature: 99 99.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  Company comment:Based on the current available information and temporal association between the use of the product and the onset date of the reported event of pyrexia, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event of pyrexia, a causal relationship cannot be excluded.
Vaccinated pt admitted to inpatient facility with covid infection. No info available on vaccination type, location, manufacturer, date, dose, route, etc.
MMR (Rt leg) & Varicella (Lt leg) given child fine no severe reaction (was observed approx 45 min). Other than injection sites slightly red. Mother called next day (6-12-12) stating right leg (where MMR given) was red the entire leg. Advised to go to ER. Mother states gave BENADRYL and redness went away.
Patient received Monovalent COVID-19 vaccine. Recommendations updated on 9/2/2022 to discontinue Monovalent COVID-19 Boosters and to begin using BIVALENT COVID-19 Boosters.
Sometime in April 2022, red bumps appeared on my right ankle. They gradually spread all over the rest of my body over a period of at least six months. The greatest concentration of bumps appeared around one of my vaccine injection sites. I saw my PCP on 4/14/2022. She diagnosed me with irritant contact dermatitis, and she referred me to a dermatologist. At that point, the rash was just on my shoulders, torso, arms, flank, back, and chest. The bumps were also accompanied by itching. I saw the first dermatologist on 5/23/2022. The dermatologist diagnosed prurigo nodularis. The dermatologist noted, "Rash located on right leg and trunk. Rash is bumpy, itchy, painful, red, and moderate in severity. The rash has been present for months." She recommended OTC treatments (e.g. EUCERIN, fragrance-free moisturizers) and hydrocolloid dressing. I took her advice, and my condition seemed to improve. I went back to that dermatologist for a follow-up on 10/25/2022. The dermatologist noted, "Chief complaint prurigo nodularis noted on May 23, 2022. She was seen on May 23, 2022, at which time the following treatment regimen was given, recommend the following: over-the-counter treatments, hydrocolloid dressings daily. Interval history; Rash improved on upper extremities and back." She noted in a separate paragraph that it was "dermatitis unspecified." I underwent a punch biopsy the same day. In the subsequent notes, she wrote, "The pathology shows verruca vulgaris. Reassure benign." I underwent vaccinations for influenza and pneumonia on 10/12/2022. I then received a Pfizer Bivalent booster (GJ5342) on 10/21/2022. The rash worsened between December 2022 and January 2023. I saw a new dermatologist for the first time on 2/15/2023. The notes read, "Follow-up for prurigo nodularis. Two lesions were injected with intralesional KENALOG. The patient followed the treatment plan as directed." He also wrote, "Urticaria on lower sternum, left ulnar palm, and right radial palm. Increase dosage of antihistamine to twice a day and take hydroxyzine for sleep." He then ordered bloodwork, and the results were normal. He prescribed clobetasol topical cream. He then included, "Psoriasis on the right inferior midback. Triamcinolone ointment as needed." I went back to the dermatologist on 4/17/2023. The aforementioned notes were the combined notes for 2/15/2023 and 4/17/2023. On 4/17/2023, he performed two shave biopsies on the skin of my back. He also did two more intralesional KENALOG injections that day. I am currently awaiting the results of the shave biopsies. I am due for a follow-up visit in July 2023.
Patient came in to subsequent vaccine clinic and had a second dose of the same flu vaccine. Patient previously had a flu shot administered on 9/30/21 by a different immunizer. It was unbeknownst to second immunizer until after the clinic/administration that she had been there prior for a flu shot.  Patient and the patient's primary care doctor have been contacted and patient is experiencing no adverse effects.
Two days after administration patient reported to pharmacy redness and swelling at injection site. She described swelling as size of her fist. We referred her to her doctor. She said MD instructed her to monitor over weekend and follow up Monday in his office.
Expired COVID-19, Moderna, vaccine was administer to patient 07/19/2021. Moderna vial (lot #040C21A) was opened 07/16/2021. Patient presented to Hospital for COVID-19 Booster. I drew up and administered expired vaccine. Patient was monitored for fifteen minutes following vaccine administration in left deltoid. Patient denied any adverse reactions prior to leaving clinc.
Pt reports that she began to feel dizzy during the observation period, however, did not report immediately.  While leaving vaccination area, reported that she was feeling dizzy, light-headed, and a little nauseous, but only while sitting. (Preferred to stand).  Patient was escorted to urgent care for evaluation.
Acute urticaria. Treatment: 9/27/12 Betamethasone Acetate 3mg, Betamethasone sodium phosphate 3mg and Hydroxyzine 25mg IM. 10/1/12 Betamethasone Acetate 3mg, Betamethasone sodium phosphate 3mg IM and prescription for Medrol Dose Pak 4mg. Take as directed.
I had a temperature of 101.1 from midnight until 5:00pm. I also was vomiting and had diarrhea during that time.
27SEP AM t105, 27SEP PM temp 103; family MD notified by mom; mom referred to ER by MD office; 28SEP temp nl;
This spontaneous report was received from a Registered Nurse referring to unspecified number of patients of unknown age and gender. The patients' concurrent conditions and medical history were not provided. On unknown dates, the patients were vaccinated with the improperly stored doses of PROQUAD (Merck) lot #: L031601, expiration date on 18-FEB-2017, lot #: L034931, expiration date on 03-MAR-2017 and lot#: L041629, expiration date on 22-APR-2017 (dose number, strength and anatomical location were not provided). The vaccines were stored in a temperature of 6F during 72 hours. Previous temperature excursion was 40.1F for 50 minutes. No adverse events were reported. No product quality issue was involved. This is one of two reports received from the same source. Additional information has been requested.
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 03-MAR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds 0.5 ml Vls 10 SDV (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had an excursion of 27 degrees Fahrenheit (-2.77 degrees Celsius) (lowest recorded temperature) for 1500 hours (sum of hours in excursion). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
2 days p/vax pt exp pain in the rt deltoid region; area was hard & tender to touch; 19JUL93 is hardly able to left rt arm;
Approx 8 cm x 8 cm area of Rt deltoid redness, hardness, swelling pain noted by 1-8-13. Did not come to clinic or report until today 1-15-13.
Full body aches and pain so bad it woke me up. Legs, back, arm and injection site hurt so bad I could barely move. OCT pain killers and a heating pad helped enough. Was very sore and stiff all day, OTC helped enough, but pain lasted all day. Decreased mobility and range of motion all day. No fever, pain almost fully gone on the next day.
weakness, fever 100.5, cough, headache, started yesterday, denies sob or cp, was walking to restroom and had fall landing on carpet, no injury from fall, able to get him self up,  usually uses walker to walk around but not when he fell,
A non-serious spontaneous report of hives has been received from a health professional concerning a sever-year-old male, subsequent to FLUMIST. The patient's past medical history included no allergies and he had received FLUMIST last year with no reaction. No concomitant medications have been reported for this patient. The patient received FLUMIST on 27-Oct-2011 at 9.00AM. On 27-Oct-2011 at 04.00PM, the patient experienced hives and again at 8.00PM. The outcome of event hives was unknown.
Severe pain and loss of mobility first in left shoulder and later in right shoulder. Within a few days there was pain also in both hips.
Reported by patients wife to me by phone on 1/21/13. Spiked fever of 103 F. Described condition as "asthenia" to me. Muscle aches and pain. Felt deathly ill. Couldn't get up. Pulse of 140. Symptoms lasted for 15 hours. Fever subsided gradually over this time. After 2 days patient was back to normal.
Pt received vaccines on 3/25/02. Pt was seen on Sunday, 4/4/02. Her left leg has a 4 1/2cm X 2 1/4cm hard, red and raised area on left thigh. MMR (SC) and DTAP (IM) were given in left thigh.
on 7/22/2023, patient presented to clinic due to a dog bite of right hand - the patient and her children were appraoched by a dog who seemed friendly, she pet him, called Animal control, reached back down to pet the dog when the dog bit her on the right hand and fled. Patient went to clinic that day and received the tetanus shot. Per patient note 7/26/2023, on Sunday 7/23/23 developed body soreness. 7/24/23 back and neck were hurting, chalked it up to being target from walking. 7/25/2023 her neck, eye, right arm were twitching. 7/26/23 (day she presented to Hospital ED her legs and neck were tight, can barely open her mouth, and very sore and tight. Was transferred from Hospital to another Hospital, where she remains hospitalized as of 8/4/2023. Per doctor notes 7/26/23, patient was having twitching of left neck and face with body aches, sore throat, and sometimes difficulty swallowing. At hospital, as of 8/2/23, patient has continued to have chills, some muscle twitching, but now improved. is on IV metronidazole, flagyl,and rabies vaccines have been administered by the hospital.
sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm at the injection site) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm at the injection site). At the time of the report, VACCINATION SITE PAIN (sore arm at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications were unknown.  Treatment for the event is unknown.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up includes updated email address. Non-significant information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Lightheadedness and dizziness resolved within 30 minutes after resting and drinking water.
Patient was vaccinated already this flu season. Received a flu vaccine today, but also received a flu vaccine 10/22/21
I was positive for COVID-19 on 13FEB2023, I was feeling like it was a bad sinus infection. juicy cough, headache and lots of head congestion. I lost the since of taste and smell, I was very fatigued. I called the doctor and I wasn't prescribed any medication.  I started feeling better few days later.
The pt experienced a rash covering entire body, itching, complained of feeling cold. Treated with Benadryl. Temp - 97.2, Pulse - 88, Respirations - 20, blood pressure - 120/80
I was given Tdap booster shot.  Initial pain at site of injection which has persisted for 4 days.  Redness at injection site with diameter about 30 millimeters. There was also swelling. I have put ice on the area and taking Motrin for pain.